Sage Journals: Discover world-class research

Abstract

Data are limited regarding how academic medical centers (AMCs) deal with medication use that represents a departure from product labeling; has reasonable rationale for use, but insufficient evidence to allay safety, efficacy, and cost-effectiveness concerns; yet is not clinical research (defined as innovative off-label medication use). This report describes national trends in management of innovative off-label medication use. A cross-sectional survey of US AMCs was conducted. Survey questionnaires were directed to drug information centers or pharmacy directors. Of 469 AMCs contacted, 104 responded (22%). Fifty-nine AMCs identified innovative off-label use as a challenge. Only 18 AMCs developed strategies to address this issue: 12 requiring initial reviews and 8 requiring clinical monitoring. Sixty-five AMCs indicated interest in data sharing of clinical outcomes for innovative off-label protocol(s). Innovative off-label medication use is a widely recognized challenge; however, few prospectively active AMC responses exist. The authors suggest development of systematic structured approaches within and across AMCs.

Keywords

off-label innovative off-label drug use medication use medication safety

Get full access to this article

View all access options for this article.

References

US Food and Drug Administration . “Off-label” and investigational use of marketed drugs, biologics, and medical devices: guidance for institutional review boards and clinical investigators 1998 update. Available at: http://www.fda.gov/oc/ohrt/irbs/offlabel.html. Accessed July 26, 2005.

Henry V. Off-label prescribing: legal implications. J Leg Med.1999;20:365-383.

Blum RS. Legal considerations in off-label medication prescribing. Arch Intern Med. 2002;162:1777-1779.

Cohen PJ. “Off-label” use of prescription drugs: legal, clinical and policy considerations. Eur J Anaesthesiol. 1997;14: 231-235.

Zindrick MR , Bunch WH. Orthopaedic surgery and Food and Drug Administration off-label uses. Clin Orthop. 2000;(378): 31-38.

Choonara I , Conroy S. Unlicensed and off-label drug use in children: implications and safety. Drug Safety. 2002;25:1-5.

Horen B , Montastruc JL , Lapeyre-Mestre M. Adverse drug reactions and off-label use in paediatric outpatients. Br J Clin Pharmacol. 2002;54:665-670.

Turner S , Nunn AJ , Fielding K , Choonara I. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr. 1999;85:965-968.

Conroy S. Unlicensed and off-label drug use: issues and recommendations. Pediatr Drugs. 2002;4:353-359.

10.

Association of American Medical Colleges . Council of Teaching Hospitals and Health Systems alphabetical listing. Available at: http://www.aamc.org/members/listings/thalpha.htm. Accessed January 5, 2004.

11.

Mannebach MR , Ascione FJ , Gaither CA , Bagozzi RP , Cohen IRA , Ryan ML. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals. Am J Health Syst Pharm. 1999;56:622-628.

12.

Pedersen CA , Schneider PJ , Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing-2004. Am J Health Syst Pharm. 2005; 62:378-390.

13.

Ansani NT , Fedutes BF , Skledar SJ , et al. Practical approach to grading evidence for formulary recommendations. Am J Health Syst Pharm. 2005;62:1498-1501.

14.

Office for Human Research Protections Web site. Available at: http://www.hhs.gov/ohrp. Accessed January 25, 2006.

15.

The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington, DC: US Department of Health, Education, and Welfare; 1979:7-14.

16.

American Academy of Pediatrics . Unapproved uses of approved drugs: the physician, the package insert, and the Food and Drug Administration. Pediatrics. 1996;98:143-145.

17.

American Academy of Pediatrics Committee on Drugs . Uses of drug not described in the package insert (off-label uses). Pediatrics. 2002;110:181-183.

United States Medical Practice Summary

Abstract

Keywords

Get full access to this article

References